Vienna, Austria

ESTRO 2025

Session

Monday
May 05
10:30 - 11:30
Stolz 2
Head & neck 4
Hans Langendijk, The Netherlands;
Marlen Haderlein, Germany
Poster Discussions are presented in one of the sessions scheduled at the two poster discussion theatres. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will be recorded and made available via the online platfrom and mobile app.
Poster Discussions
Clinical
Head & Neck
10:30 - 10:36
Prospective evaluation of Next Generation Sequencing (NGS) plasma HPVDNA assay for treatment response estimation in head and neck cancer
Shreerang Bhide, United Kingdom
E25-3227
10:36 - 10:42
ITHACA-CHRONOS: Impact of Radiotherapy Timing on Toxicity and Outcomes in Head and Neck Cancer Patients
Mariangela Massaccesi, Italy
E25-3468
10:42 - 10:48
Federated Prediction Models and External Validation for Radiotherapy Outcomes in Head and Neck Cancer using F.A.I.R. Clinical and Radiomics Data
Leonard Wee, The Netherlands
E25-2496
10:54 - 11:00
International Consensus Guidelines on the Delineation of Radiotherapy Target Volumes for NPC after Induction Chemotherapy
Nejla Fourati, Tunisia
E25-4153
11:00 - 11:06
A Systematic Review and meta-analysis of the prognostic value of tumor response measurements during radiotherapy for head and neck cancers
Sidsel Poulsen, Denmark
E25-1209
11:06 - 11:12
Subsequent Survival for Patients with Progression-Free 24 Months in Nasopharyngeal Carcinoma: A Comprehensive Nationwide Population-Based Analysis
Yang Liu, China
E25-1902
11:12 - 11:18
Submandibular and parotid gland sparing versus parotid gland sparing alone in head and neck cancers : assessor-blinded randomised controlled trial"
MUTHUVEERAPPAN SATHAPPAN, India
E25-3247
11:18 - 11:24
MRI far exceeded CT/PET and clinical benchmark model for local recurrence prediction in oropharyngeal cancer: a deep learning-based investigation
Nanna Sijtsema, The Netherlands
E25-2447
11:24 - 11:30
Recurrent patterns in NPC patients and risks leading to inaccurate delineation in marginal failure in the era of intensity-modulated radiotherapy
Shu Zhang, China
E25-185